{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:07:32Z","timestamp":1793192852200,"version":"4.5.0"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07331-3","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:17:29Z","timestamp":1763464649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Regulation of m6A methylation in the immune microenvironment in the development of diabetes mellitus"],"prefix":"10.1186","volume":"23","author":[{"given":"Haoyue","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanning","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8501-6777","authenticated-orcid":false,"given":"Yue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"7331_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","volume":"22","author":"D Wiener","year":"2021","unstructured":"Wiener D, Schwartz S. The epitranscriptome beyond m(6)A. Nat Rev Genet. 2021;22:119\u201331.","journal-title":"Nat Rev Genet"},{"key":"7331_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in cancer progression. Mol Cancer. 2020;19:88.","journal-title":"Mol Cancer"},{"key":"7331_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He L, et al. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18:176.","journal-title":"Mol Cancer"},{"key":"7331_CR4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, Hsu PJ, Chen YS, Yang YG. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28:616\u201324.","journal-title":"Cell Res"},{"key":"7331_CR5","doi-asserted-by":"publisher","first-page":"1030728","DOI":"10.3389\/fimmu.2022.1030728","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. The m6A methylation profiles of immune cells in type 1 diabetes mellitus. Front Immunol. 2022;13:1030728.","journal-title":"Front Immunol"},{"key":"7331_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-023-01782-2","volume":"22","author":"H Zhuang","year":"2023","unstructured":"Zhuang H, et al. The role of m6A methylation in therapy resistance in cancer. Mol Cancer. 2023;22:91.","journal-title":"Mol Cancer"},{"key":"7331_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ejhf.1672","volume":"22","author":"T Berulava","year":"2020","unstructured":"Berulava T, et al. Changes in m6A RNA methylation contribute to heart failure progression by modulating translation. Eur J Heart Fail. 2020;22:54\u201366.","journal-title":"Eur J Heart Fail"},{"key":"7331_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-020-00872-8","volume":"13","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Shi Y, Shen H, Xie W. m(6)A-binding proteins: the emerging crucial performers in epigenetics. J Hematol Oncol. 2020;13:35.","journal-title":"J Hematol Oncol"},{"key":"7331_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285\u201395.","journal-title":"Nat Cell Biol"},{"key":"7331_CR10","doi-asserted-by":"crossref","unstructured":"Azzam SK, Alsafar H, Sajini AA. FTO m6A demethylase in obesity and cancer: implications and underlying molecular mechanisms. Int J Mol Sci 23, (2022).","DOI":"10.3390\/ijms23073800"},{"key":"7331_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Diabetes Atlas. Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271\u201381.","journal-title":"Diabetes Res Clin Pract"},{"key":"7331_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88\u201398.","journal-title":"Nat Rev Endocrinol"},{"key":"7331_CR13","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1172\/JCI129188","volume":"129","author":"LI Hudish","year":"2019","unstructured":"Hudish LI, Reusch JE, Sussel L. \u03b2 cell dysfunction during progression of metabolic syndrome to type 2 diabetes. J Clin Invest. 2019;129:4001\u20138.","journal-title":"J Clin Invest"},{"key":"7331_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/1479164119827611","volume":"16","author":"CJ Nolan","year":"2019","unstructured":"Nolan CJ, Prentki M. Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: time for a conceptual framework shift. Diab Vasc Dis Res. 2019;16:118\u201327.","journal-title":"Diab Vasc Dis Res"},{"key":"7331_CR15","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","volume":"383","author":"SE Kahn","year":"2014","unstructured":"Kahn SE, Cooper ME, Prato SD. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383:1068\u201383.","journal-title":"Lancet"},{"key":"7331_CR16","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1210\/jc.2004-0395","volume":"89","author":"EE Kershaw","year":"2004","unstructured":"Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548\u201356.","journal-title":"J Clin Endocrinol Metab"},{"key":"7331_CR17","doi-asserted-by":"crossref","unstructured":"Kruczkowska W et al. Senescent adipocytes and type 2 diabetes - current knowledge and perspective concepts. Biomol Concepts 15, (2024).","DOI":"10.1515\/bmc-2022-0046"},{"key":"7331_CR18","doi-asserted-by":"crossref","unstructured":"Dilworth L, Facey A, Omoruyi F. Diabetes mellitus and its metabolic complications: the role of adipose tissues. Int J Mol Sci 22, (2021).","DOI":"10.3390\/ijms22147644"},{"key":"7331_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12016-025-09041-6","volume":"68","author":"L Xu","year":"2025","unstructured":"Xu L, Shen T, Li Y, Wu X. The role of M(6)A modification in autoimmunity: emerging mechanisms and therapeutic implications. Clin Rev Allergy Immunol. 2025;68:29.","journal-title":"Clin Rev Allergy Immunol"},{"key":"7331_CR20","doi-asserted-by":"crossref","unstructured":"Bornaque F et al. Glucose regulates m6A methylation of RNA in pancreatic islets. Cells 11, (2022).","DOI":"10.3390\/cells11020291"},{"key":"7331_CR21","doi-asserted-by":"publisher","first-page":"651142","DOI":"10.3389\/fcell.2021.651142","volume":"9","author":"C Chen","year":"2021","unstructured":"Chen C, et al. Co-expression network revealed roles of RNA m(6)A methylation in human \u03b2-Cell of type 2 diabetes mellitus. Front Cell Dev Biol. 2021;9:651142.","journal-title":"Front Cell Dev Biol"},{"key":"7331_CR22","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2337\/db12-1474","volume":"62","author":"E Bachar-Wikstrom","year":"2013","unstructured":"Bachar-Wikstrom E, et al. Stimulation of autophagy improves Endoplasmic reticulum stress-induced diabetes. Diabetes. 2013;62:1227\u201337.","journal-title":"Diabetes"},{"key":"7331_CR23","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00125-009-1347-2","volume":"52","author":"M Masini","year":"2009","unstructured":"Masini M, et al. Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia. 2009;52:1083\u20136.","journal-title":"Diabetologia"},{"key":"7331_CR24","first-page":"S92","volume":"27s","author":"YH Lee","year":"2019","unstructured":"Lee YH, Kim J, Park K, Lee MS. \u03b2-cell autophagy: mechanism and role in \u03b2-cell dysfunction. Mol Metab. 2019;27s:S92\u2013103.","journal-title":"Mol Metab"},{"key":"7331_CR25","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1080\/15548627.2023.2200625","volume":"19","author":"T Wu","year":"2023","unstructured":"Wu T, et al. NR3C1\/Glucocorticoid receptor activation promotes pancreatic \u03b2-cell autophagy overload in response to glucolipotoxicity. Autophagy. 2023;19:2538\u201357.","journal-title":"Autophagy"},{"key":"7331_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41423-019-0307-0","volume":"17","author":"A Paramasivam","year":"2020","unstructured":"Paramasivam A, Priyadharsini JV, Raghunandhakumar S. Implications of m6A modification in autoimmune disorders. Cell Mol Immunol. 2020;17:550\u20131.","journal-title":"Cell Mol Immunol"},{"key":"7331_CR27","doi-asserted-by":"publisher","first-page":"482","DOI":"10.2337\/diabetes.54.2.482","volume":"54","author":"Y Li","year":"2005","unstructured":"Li Y, et al. beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1. Diabetes. 2005;54:482\u201391.","journal-title":"Diabetes"},{"key":"7331_CR28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s42255-019-0089-9","volume":"1","author":"DF De Jesus","year":"2019","unstructured":"De Jesus DF, et al. m(6)A mRNA methylation regulates human \u03b2-Cell biology in physiological States and in type 2 diabetes. Nat Metab. 2019;1:765\u201374.","journal-title":"Nat Metab"},{"key":"7331_CR29","doi-asserted-by":"publisher","first-page":"101209","DOI":"10.1016\/j.molmet.2021.101209","volume":"48","author":"L Regu\u00e9","year":"2021","unstructured":"Regu\u00e9 L, et al. RNA m6A reader IMP2\/IGF2BP2 promotes pancreatic \u03b2-cell proliferation and insulin secretion by enhancing PDX1 expression. Mol Metab. 2021;48:101209.","journal-title":"Mol Metab"},{"key":"7331_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cmet.2023.11.018","volume":"36","author":"BJ Weidemann","year":"2024","unstructured":"Weidemann BJ, et al. Repression of latent NF-\u03baB enhancers by PDX1 regulates \u03b2 cell functional heterogeneity. Cell Metab. 2024;36:90\u2013e102107.","journal-title":"Cell Metab"},{"key":"7331_CR31","doi-asserted-by":"publisher","first-page":"109540","DOI":"10.1016\/j.isci.2024.109540","volume":"27","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. Islet-resident macrophage-derived miR-155 promotes \u03b2 cell decompensation via targeting PDX1. iScience. 2024;27:109540.","journal-title":"iScience"},{"key":"7331_CR32","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.2337\/db17-0313","volume":"66","author":"M Zhu","year":"2017","unstructured":"Zhu M, et al. Hyperlipidemia-Induced MicroRNA-155-5p improves \u03b2-Cell function by targeting Mafb. Diabetes. 2017;66:3072\u201384.","journal-title":"Diabetes"},{"key":"7331_CR33","doi-asserted-by":"publisher","first-page":"154734","DOI":"10.1016\/j.metabol.2021.154734","volume":"118","author":"LR Cataldo","year":"2021","unstructured":"Cataldo LR, et al. The MafA-target gene PPP1R1A regulates GLP1R-mediated amplification of glucose-stimulated insulin secretion in \u03b2-cells. Metabolism. 2021;118:154734.","journal-title":"Metabolism"},{"key":"7331_CR34","doi-asserted-by":"publisher","first-page":"910868","DOI":"10.3389\/fendo.2022.910868","volume":"13","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, et al. The m(6)A methyltransferase METTL3 ameliorates Methylglyoxal-Induced impairment of insulin secretion in pancreatic \u03b2 cells by regulating MafA expression. Front Endocrinol (Lausanne). 2022;13:910868.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7331_CR35","doi-asserted-by":"crossref","unstructured":"Singh T et al. MafA expression preserves immune homeostasis in human and mouse Islets. Genes (Basel) 9, (2018).","DOI":"10.3390\/genes9120644"},{"key":"7331_CR36","doi-asserted-by":"publisher","first-page":"9074","DOI":"10.1038\/s41598-019-45528-x","volume":"9","author":"T Singh","year":"2019","unstructured":"Singh T, et al. Loss of MafA and MafB expression promotes islet inflammation. Sci Rep. 2019;9:9074.","journal-title":"Sci Rep"},{"key":"7331_CR37","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.bbadis.2019.04.011","volume":"1865","author":"J Liu","year":"2019","unstructured":"Liu J, et al. METTL14 is essential for \u03b2-cell survival and insulin secretion. Biochim Biophys Acta Mol Basis Dis. 2019;1865:2138\u201348.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"7331_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2337\/db23-0360","volume":"73","author":"J Sun","year":"2024","unstructured":"Sun J, et al. Mettl3-Mediated m6A methylation controls pancreatic bipotent progenitor fate and islet formation. Diabetes. 2024;73:237\u201349.","journal-title":"Diabetes"},{"key":"7331_CR39","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s00125-023-05900-z","volume":"66","author":"X Li","year":"2023","unstructured":"Li X, et al. Deficiency of WTAP in islet beta cells results in beta cell failure and diabetes in mice. Diabetologia. 2023;66:1084\u201396.","journal-title":"Diabetologia"},{"key":"7331_CR40","doi-asserted-by":"publisher","first-page":"155339","DOI":"10.1016\/j.metabol.2022.155339","volume":"138","author":"X Li","year":"2023","unstructured":"Li X, Yang Y, Chen Z. Downregulation of the m(6)A reader protein YTHDC1 leads to islet \u03b2-cell failure and diabetes. Metabolism. 2023;138:155339.","journal-title":"Metabolism"},{"key":"7331_CR41","doi-asserted-by":"publisher","first-page":"10835","DOI":"10.1038\/s41598-025-93799-4","volume":"15","author":"X Zhang","year":"2025","unstructured":"Zhang X, Shan A, Chen J, Cao Y, Jiang X. Mettl3 deficiency leads to impaired insulin secretion via regulating Ire1a of mature \u03b2-cells in mice. Sci Rep. 2025;15:10835.","journal-title":"Sci Rep"},{"key":"7331_CR42","doi-asserted-by":"crossref","unstructured":"Men LL, Sun J, Ren DC. Deletion of METTL14 in beta cells in adult mice induces diabetes related to increased ER stress. Diabetes 68, (2019).","DOI":"10.2337\/db19-362-OR"},{"key":"7331_CR43","doi-asserted-by":"crossref","unstructured":"Ren DC, Sun J. Deletion of YTHDF2 in beta cells results in glucose intolerance. Diabetes 69, (2020).","DOI":"10.2337\/db20-53-OR"},{"key":"7331_CR44","doi-asserted-by":"crossref","unstructured":"Kobayashi M et al. The RNA methyltransferase complex of WTAP, METTL3, and METTL14 regulates mitotic clonal expansion in adipogenesis. Mol Cell Biol 38, (2018).","DOI":"10.1128\/MCB.00116-18"},{"key":"7331_CR45","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41589-020-0601-2","volume":"16","author":"L Wang","year":"2020","unstructured":"Wang L, et al. NADP modulates RNA m(6)A methylation and adipogenesis via enhancing FTO activity. Nat Chem Biol. 2020;16:1394\u2013402.","journal-title":"Nat Chem Biol"},{"key":"7331_CR46","doi-asserted-by":"publisher","first-page":"109437","DOI":"10.1016\/j.jnutbio.2023.109437","volume":"122","author":"C Huang","year":"2023","unstructured":"Huang C, et al. Branched-chain amino acids prevent obesity by inhibiting the cell cycle in an NADPH-FTO-m(6)A coordinated manner. J Nutr Biochem. 2023;122:109437.","journal-title":"J Nutr Biochem"},{"key":"7331_CR47","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1080\/15548627.2019.1659617","volume":"16","author":"X Wang","year":"2020","unstructured":"Wang X, et al. m(6)A mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7. Autophagy. 2020;16:1221\u201335.","journal-title":"Autophagy"},{"key":"7331_CR48","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/cr.2014.151","volume":"24","author":"X Zhao","year":"2014","unstructured":"Zhao X, et al. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res. 2014;24:1403\u201319.","journal-title":"Cell Res"},{"key":"7331_CR49","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/nu8020102","volume":"8","author":"Y Jiao","year":"2016","unstructured":"Jiao Y, Zhang J, Lu L, Xu J, Qin L. The Fto gene regulates the proliferation and differentiation of Pre-Adipocytes in vitro. Nutrients. 2016;8:102.","journal-title":"Nutrients"},{"key":"7331_CR50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2337\/db17-0356","volume":"67","author":"H Zhao","year":"2018","unstructured":"Zhao H, et al. Exosomes from adipose-Derived stem cells attenuate adipose inflammation and obesity through polarizing M2 macrophages and Beiging in white adipose tissue. Diabetes. 2018;67:235\u201347.","journal-title":"Diabetes"},{"issue":"S2090","key":"7331_CR51","first-page":"1232(25)00369","volume":"24","author":"B Wang","year":"2025","unstructured":"Wang B et al. Exosomal miR-1246 of adipose stem cells attenuates obesity by polarizing M2 macrophages, reducing fat mass, and Beiging of white adipose tissue. J Adv Res. 2025;24: S2090-1232(25)00369\u20138.","journal-title":"J Adv Res"},{"key":"7331_CR52","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1210\/en.2003-0288","volume":"144","author":"CH Lee","year":"2003","unstructured":"Lee CH, Olson P, Evans RM. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology. 2003;144:2201\u20137.","journal-title":"Endocrinology"},{"key":"7331_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00018-023-05076-0","volume":"81","author":"X Huang","year":"2024","unstructured":"Huang X, He W, Fan S, Li H, Ye G. IGF2BP3-mediated enhanced stability of MYLK represses MSC adipogenesis and alleviates obesity and insulin resistance in HFD mice. Cell Mol Life Sci. 2024;81:17.","journal-title":"Cell Mol Life Sci"},{"key":"7331_CR54","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1096\/fj.201801393RRR","volume":"33","author":"Q Jiang","year":"2019","unstructured":"Jiang Q, et al. MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m(6)A-YTHDF1-dependent mechanism. Faseb J. 2019;33:2971\u201381.","journal-title":"Faseb J"},{"key":"7331_CR55","doi-asserted-by":"publisher","first-page":"e2301645","DOI":"10.1002\/advs.202301645","volume":"10","author":"Q Kang","year":"2023","unstructured":"Kang Q, et al. Adipose METTL14-Elicited N(6) -Methyladenosine promotes Obesity, insulin Resistance, and NAFLD through suppressing \u03b2 adrenergic signaling and lipolysis. Adv Sci (Weinh). 2023;10:e2301645.","journal-title":"Adv Sci (Weinh)"},{"key":"7331_CR56","doi-asserted-by":"publisher","first-page":"ra127","DOI":"10.1126\/scisignal.aab3357","volume":"8","author":"CY Wang","year":"2015","unstructured":"Wang CY, et al. Loss of FTO in adipose tissue decreases Angptl4 translation and alters triglyceride metabolism. Sci Signal. 2015;8:ra127.","journal-title":"Sci Signal"},{"key":"7331_CR57","doi-asserted-by":"crossref","unstructured":"Barchetta I et al. Angiopoietin-like protein 4 overexpression in visceral adipose tissue from obese subjects with impaired glucose metabolism and relationship with lipoprotein lipase. Int J Mol Sci 21, (2020).","DOI":"10.3390\/ijms21197197"},{"key":"7331_CR58","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12986-023-00762-z","volume":"20","author":"Y Li","year":"2023","unstructured":"Li Y, et al. METTL3 exacerbates insulin resistance in hepatocytes by regulating m(6)A modification of cytochrome P450 2B6. Nutr Metab (Lond). 2023;20:40.","journal-title":"Nutr Metab (Lond)"},{"key":"7331_CR59","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/cr.2013.64","volume":"23","author":"X Liu","year":"2013","unstructured":"Liu X, et al. Brown adipose tissue transplantation improves whole-body energy metabolism. Cell Res. 2013;23:851\u20134.","journal-title":"Cell Res"},{"key":"7331_CR60","doi-asserted-by":"publisher","first-page":"e52348","DOI":"10.15252\/embr.202052348","volume":"22","author":"R Wu","year":"2021","unstructured":"Wu R, et al. m6A methylation promotes white-to-beige fat transition by facilitating Hif1a translation. EMBO Rep. 2021;22:e52348.","journal-title":"EMBO Rep"},{"key":"7331_CR61","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s41467-020-15488-2","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. METTL3 is essential for postnatal development of brown adipose tissue and energy expenditure in mice. Nat Commun. 2020;11:1648.","journal-title":"Nat Commun"},{"key":"7331_CR62","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/jdi.14327","volume":"16","author":"J Peng","year":"2025","unstructured":"Peng J, Zhu H, Ruan B, Duan Z, Cao M. miR-155 promotes m6A modification of SOX2 mRNA through targeted regulation of HIF-1\u03b1 and delays wound healing in diabetic foot ulcer in vitro models. J Diabetes Investig. 2025;16:60\u201371.","journal-title":"J Diabetes Investig"},{"key":"7331_CR63","doi-asserted-by":"publisher","first-page":"e110439","DOI":"10.15252\/embj.2021110439","volume":"41","author":"X Tao","year":"2022","unstructured":"Tao X, et al. PGE(2) -EP3 axis promotes brown adipose tissue formation through stabilization of WTAP RNA methyltransferase. Embo J. 2022;41:e110439.","journal-title":"Embo J"},{"key":"7331_CR64","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cmet.2015.03.006","volume":"21","author":"N Dai","year":"2015","unstructured":"Dai N, et al. IGF2BP2\/IMP2-Deficient mice resist obesity through enhanced translation of Ucp1 mRNA and other mRNAs encoding mitochondrial proteins. Cell Metab. 2015;21:609\u201321.","journal-title":"Cell Metab"},{"key":"7331_CR65","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","volume":"48","author":"X Ouyang","year":"2008","unstructured":"Ouyang X, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol. 2008;48:993\u20139.","journal-title":"J Hepatol"},{"key":"7331_CR66","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1055\/s-0028-1092753","volume":"11","author":"DK Richardson","year":"1979","unstructured":"Richardson DK, Czech MP. Diminished activities of fatty acid synthesis enzymes in insulin-resistant adipocytes from spontaneously obese rats. Horm Metab Res. 1979;11:427\u201331.","journal-title":"Horm Metab Res"},{"key":"7331_CR67","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1373\/clinchem.2008.115352","volume":"55","author":"JA Menendez","year":"2009","unstructured":"Menendez JA, Vazquez-Martin A, Ortega FJ, Fernandez-Real JM. Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. Clin Chem. 2009;55:425\u201338.","journal-title":"Clin Chem"},{"key":"7331_CR68","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbrc.2019.08.018","volume":"518","author":"W Xie","year":"2019","unstructured":"Xie W, Ma LL, Xu YQ, Wang BH, Li SM. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism. Biochem Biophys Res Commun. 2019;518:120\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"7331_CR69","doi-asserted-by":"publisher","first-page":"e14491","DOI":"10.1111\/cbdd.14491","volume":"103","author":"M Guo","year":"2024","unstructured":"Guo M, Su F, Chen Y, Su B. Methyltransferase METTL3-mediated maturation of miR-4654 facilitates high glucose-induced apoptosis and oxidative stress in lens epithelial cells via decreasing SOD2. Chem Biol Drug Des. 2024;103:e14491.","journal-title":"Chem Biol Drug Des"},{"key":"7331_CR70","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1007\/s00125-022-05719-0","volume":"65","author":"EM Lessieur","year":"2022","unstructured":"Lessieur EM, et al. ICAM-1 on the luminal surface of endothelial cells is induced to a greater extent in mouse retina than in other tissues in diabetes. Diabetologia. 2022;65:1734\u201344.","journal-title":"Diabetologia"},{"key":"7331_CR71","doi-asserted-by":"publisher","first-page":"277","DOI":"10.7150\/thno.63441","volume":"12","author":"L Suo","year":"2022","unstructured":"Suo L, et al. METTL3-mediated N(6)-methyladenosine modification governs pericyte dysfunction during diabetes-induced retinal vascular complication. Theranostics. 2022;12:277\u201389.","journal-title":"Theranostics"},{"key":"7331_CR72","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.18632\/aging.103130","volume":"12","author":"X Zha","year":"2020","unstructured":"Zha X, et al. Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p\/PTEN\/Akt signaling cascade through DGCR8. Aging. 2020;12:8137\u201350.","journal-title":"Aging"},{"key":"7331_CR73","doi-asserted-by":"crossref","unstructured":"Colomer-Boronat A et al. DGCR8 haploinsufficiency leads to primate-specific RNA dysregulation and pluripotency defects. Nucleic Acids Res 53, (2025).","DOI":"10.1093\/nar\/gkaf197"},{"key":"7331_CR74","doi-asserted-by":"publisher","first-page":"110498","DOI":"10.1016\/j.ygeno.2022.110498","volume":"114","author":"X Cao","year":"2022","unstructured":"Cao X, et al. m(6)A transferase METTL3 regulates endothelial-mesenchymal transition in diabetic retinopathy via LncRNA SNHG7\/KHSRP\/MKL1 axis. Genomics. 2022;114:110498.","journal-title":"Genomics"},{"key":"7331_CR75","doi-asserted-by":"publisher","first-page":"813979","DOI":"10.3389\/fimmu.2022.813979","volume":"13","author":"T Chen","year":"2022","unstructured":"Chen T, et al. ALKBH5-Mediated m(6)A modification of A20 regulates microglia polarization in diabetic retinopathy. Front Immunol. 2022;13:813979.","journal-title":"Front Immunol"},{"key":"7331_CR76","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s44321-024-00025-1","volume":"16","author":"X Chen","year":"2024","unstructured":"Chen X, et al. Lactylation-driven FTO targets CDK2 to aggravate microvascular anomalies in diabetic retinopathy. EMBO Mol Med. 2024;16:294\u2013318.","journal-title":"EMBO Mol Med"},{"key":"7331_CR77","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1186\/s12967-024-05691-w","volume":"22","author":"S Dong","year":"2024","unstructured":"Dong S, et al. METTL3-mediated m6A modification of SIRT1 mRNA affects the progression of diabetic cataracts through cellular autophagy and senescence. J Transl Med. 2024;22:865.","journal-title":"J Transl Med"},{"key":"7331_CR78","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41419-021-04484-z","volume":"13","author":"L Meng","year":"2022","unstructured":"Meng L, et al. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR LncRNA. Cell Death Dis. 2022;13:38.","journal-title":"Cell Death Dis"},{"key":"7331_CR79","doi-asserted-by":"publisher","first-page":"702579","DOI":"10.3389\/fcell.2021.702579","volume":"9","author":"W Ju","year":"2021","unstructured":"Ju W, et al. Changes in N6-Methyladenosine modification modulate diabetic cardiomyopathy by reducing myocardial fibrosis and myocyte hypertrophy. Front Cell Dev Biol. 2021;9:702579.","journal-title":"Front Cell Dev Biol"},{"key":"7331_CR80","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.yjmcc.2019.01.024","volume":"129","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, et al. Multiple roles of KLF15 in the heart: underlying mechanisms and therapeutic implications. J Mol Cell Cardiol. 2019;129:193\u20136.","journal-title":"J Mol Cell Cardiol"},{"key":"7331_CR81","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13062-022-00346-6","volume":"17","author":"T Peng","year":"2022","unstructured":"Peng T, et al. LncRNA Airn alleviates diabetic cardiac fibrosis by inhibiting activation of cardiac fibroblasts via a m6A-IMP2-p53 axis. Biol Direct. 2022;17:32.","journal-title":"Biol Direct"},{"key":"7331_CR82","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.ymthe.2022.01.002","volume":"30","author":"L Jiang","year":"2022","unstructured":"Jiang L, et al. METTL3-mediated m(6)A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy. Mol Ther. 2022;30:1721\u201340.","journal-title":"Mol Ther"},{"key":"7331_CR83","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s10020-021-00365-5","volume":"27","author":"M Li","year":"2021","unstructured":"Li M, Deng L, Xu G. METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of \u03b1-klotho. Mol Med. 2021;27:106.","journal-title":"Mol Med"},{"key":"7331_CR84","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1038\/s41467-019-09753-2","volume":"10","author":"K Tsuchiya","year":"2019","unstructured":"Tsuchiya K, et al. Caspase-1 initiates apoptosis in the absence of gasdermin D. Nat Commun. 2019;10:2091.","journal-title":"Nat Commun"},{"key":"7331_CR85","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/s41467-020-16043-9","volume":"11","author":"M Karmakar","year":"2020","unstructured":"Karmakar M, et al. N-GSDMD trafficking to neutrophil organelles facilitates IL-1\u03b2 release independently of plasma membrane pores and pyroptosis. Nat Commun. 2020;11:2212.","journal-title":"Nat Commun"},{"key":"7331_CR86","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-022-00350-8","volume":"27","author":"J Lan","year":"2022","unstructured":"Lan J, Xu B, Shi X, Pan Q, Tao Q. WTAP-mediated N(6)-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy. Cell Mol Biol Lett. 2022;27:51.","journal-title":"Cell Mol Biol Lett"},{"key":"7331_CR87","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41419-021-04156-y","volume":"12","author":"Z Lu","year":"2021","unstructured":"Lu Z, et al. METTL14 aggravates podocyte injury and glomerulopathy progression through N(6)-methyladenosine-dependent downregulating of Sirt1. Cell Death Dis. 2021;12:881.","journal-title":"Cell Death Dis"},{"key":"7331_CR88","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41419-023-05658-7","volume":"14","author":"J Hu","year":"2023","unstructured":"Hu J, et al. Long noncoding RNA ENST00000436340 promotes podocyte injury in diabetic kidney disease by facilitating the association of PTBP1 with RAB3B. Cell Death Dis. 2023;14:130.","journal-title":"Cell Death Dis"},{"key":"7331_CR89","doi-asserted-by":"publisher","first-page":"167022","DOI":"10.1016\/j.bbadis.2024.167022","volume":"1870","author":"D Yuan","year":"2024","unstructured":"Yuan D, et al. IGF2BP3-stabilized CAMK1 regulates the mitochondrial dynamics of renal tubule to alleviate diabetic nephropathy. Biochim Biophys Acta Mol Basis Dis. 2024;1870:167022.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"7331_CR90","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41419-020-03312-0","volume":"12","author":"Z Xu","year":"2021","unstructured":"Xu Z, et al. METTL14-regulated PI3K\/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease. Cell Death Dis. 2021;12:32.","journal-title":"Cell Death Dis"},{"key":"7331_CR91","doi-asserted-by":"crossref","unstructured":"Zhou C et al. FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1. J Clin Invest 133, (2023).","DOI":"10.1172\/JCI160517"},{"key":"7331_CR92","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.7150\/thno.104179","volume":"15","author":"X Ping","year":"2025","unstructured":"Ping X, et al. Deciphering single-cell landscape unravels cell-type-specific functional roles of RNA m(6)A modification in atherosclerosis. Theranostics. 2025;15:4785\u2013807.","journal-title":"Theranostics"},{"key":"7331_CR93","doi-asserted-by":"crossref","unstructured":"Chien CS et al. METTL3-dependent N(6)-methyladenosine RNA modification mediates the atherogenic inflammatory cascades in vascular endothelium. Proc Natl Acad Sci U S A 118, (2021).","DOI":"10.1073\/pnas.2025070118"},{"key":"7331_CR94","first-page":"752","volume":"9","author":"J Chen","year":"2019","unstructured":"Chen J, Wang C, Fei W, Fang X, Hu X. Epitranscriptomic m6A modification in the stem cell field and its effects on cell death and survival. Am J Cancer Res. 2019;9:752\u201364.","journal-title":"Am J Cancer Res"},{"key":"7331_CR95","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.7150\/ijbs.114988","volume":"21","author":"H Zhang","year":"2025","unstructured":"Zhang H, et al. Epigenetic orchestration of RNA m(6)A methylation in wound healing and post-wound events. Int J Biol Sci. 2025;21:4927\u201341.","journal-title":"Int J Biol Sci"},{"key":"7331_CR96","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1111\/febs.14354","volume":"285","author":"SW Wong","year":"2018","unstructured":"Wong SW, Sil P, Martinez J. Rubicon: LC3-associated phagocytosis and beyond. Febs J. 2018;285:1379\u201388.","journal-title":"Febs J"},{"key":"7331_CR97","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ymthe.2021.09.016","volume":"30","author":"Z Peng","year":"2022","unstructured":"Peng Z, et al. METTL3-m(6)A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease. Mol Ther. 2022;30:932\u201346.","journal-title":"Mol Ther"},{"key":"7331_CR98","doi-asserted-by":"crossref","unstructured":"Tang Z et al. Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs. J Mol Cell Biol 14, (2023).","DOI":"10.1093\/jmcb\/mjac061"},{"key":"7331_CR99","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.gendis.2023.02.054","volume":"11","author":"L Sun","year":"2024","unstructured":"Sun L, et al. Decoding m(6)A mRNA methylation by reader proteins in liver diseases. Genes Dis. 2024;11:711\u201326.","journal-title":"Genes Dis"},{"key":"7331_CR100","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/hep.31220","volume":"73","author":"B Zhou","year":"2021","unstructured":"Zhou B, et al. N(6) -Methyladenosine reader protein YT521-B homology Domain-Containing 2 suppresses liver steatosis by regulation of mRNA stability of lipogenic genes. Hepatology. 2021;73:91\u2013103.","journal-title":"Hepatology"},{"key":"7331_CR101","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.ymthe.2022.02.021","volume":"30","author":"Y Yang","year":"2022","unstructured":"Yang Y, et al. Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma. Mol Ther. 2022;30:2342\u201353.","journal-title":"Mol Ther"},{"key":"7331_CR102","doi-asserted-by":"publisher","first-page":"780617","DOI":"10.3389\/fendo.2021.780617","volume":"12","author":"Y Luo","year":"2021","unstructured":"Luo Y, et al. Analysis of N6-Methyladenosine methylation modification in Fructose-Induced Non-Alcoholic fatty liver disease. Front Endocrinol (Lausanne). 2021;12:780617.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7331_CR103","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/j.celrep.2018.10.068","volume":"25","author":"X Zhong","year":"2018","unstructured":"Zhong X, et al. Circadian clock regulation of hepatic lipid metabolism by modulation of m(6)A mRNA methylation. Cell Rep. 2018;25:1816\u2013e18281814.","journal-title":"Cell Rep"},{"key":"7331_CR104","doi-asserted-by":"publisher","first-page":"11944","DOI":"10.1074\/jbc.RA119.008778","volume":"294","author":"L Regu\u00e9","year":"2019","unstructured":"Regu\u00e9 L, Minichiello L, Avruch J, Dai N. Liver-specific deletion of IGF2 mRNA binding protein-2\/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation. J Biol Chem. 2019;294:11944\u201351.","journal-title":"J Biol Chem"},{"key":"7331_CR105","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/gutjnl-2013-305736","volume":"63","author":"Y Simon","year":"2014","unstructured":"Simon Y, Kessler SM, Bohle RM, Haybaeck J, Kiemer AK. The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62\/IGF2BP2-2 as a promoter of NAFLD and HCC? Gut. 2014;63:861\u20133.","journal-title":"Gut"},{"key":"7331_CR106","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","volume":"61","author":"C Baeck","year":"2012","unstructured":"Baeck C, et al. Pharmacological Inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut. 2012;61:416\u201326.","journal-title":"Gut"},{"key":"7331_CR107","doi-asserted-by":"publisher","first-page":"973116","DOI":"10.3389\/fphar.2022.973116","volume":"13","author":"W Cheng","year":"2022","unstructured":"Cheng W, et al. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC. Front Pharmacol. 2022;13:973116.","journal-title":"Front Pharmacol"},{"key":"7331_CR108","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.gpb.2020.06.003","volume":"18","author":"Y Li","year":"2020","unstructured":"Li Y, et al. m(6)A regulates liver metabolic disorders and hepatogenous diabetes. Genomics Proteom Bioinf. 2020;18:371\u201383.","journal-title":"Genomics Proteom Bioinf"},{"key":"7331_CR109","doi-asserted-by":"publisher","first-page":"109968","DOI":"10.1016\/j.celrep.2021.109968","volume":"37","author":"Y Qin","year":"2021","unstructured":"Qin Y, et al. m(6)A mRNA methylation-directed myeloid cell activation controls progression of NAFLD and obesity. Cell Rep. 2021;37:109968.","journal-title":"Cell Rep"},{"key":"7331_CR110","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fphys.2019.00024","volume":"10","author":"L Li","year":"2019","unstructured":"Li L, et al. High glucose suppresses keratinocyte migration through the Inhibition of p38 MAPK\/Autophagy pathway. Front Physiol. 2019;10:24.","journal-title":"Front Physiol"},{"key":"7331_CR111","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.molcel.2013.12.014","volume":"53","author":"V Rogov","year":"2014","unstructured":"Rogov V, D\u00f6tsch V, Johansen T, Kirkin V. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol Cell. 2014;53:167\u201378.","journal-title":"Mol Cell"},{"key":"7331_CR112","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1080\/15548627.2021.1974175","volume":"18","author":"D Liang","year":"2022","unstructured":"Liang D, et al. m(6)A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin. Autophagy. 2022;18:1318\u201337.","journal-title":"Autophagy"},{"key":"7331_CR113","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s10020-021-00406-z","volume":"27","author":"J Zhou","year":"2021","unstructured":"Zhou J, Wei T, He Z. ADSCs enhance VEGFR3-mediated lymphangiogenesis via METTL3-mediated VEGF-C m(6)A modification to improve wound healing of diabetic foot ulcers. Mol Med. 2021;27:146.","journal-title":"Mol Med"},{"key":"7331_CR114","doi-asserted-by":"publisher","first-page":"111283","DOI":"10.1016\/j.intimp.2023.111283","volume":"126","author":"Y Liu","year":"2024","unstructured":"Liu Y, et al. Discovery of \u03b2-sitosterol\u2019s effects on molecular changes in rat diabetic wounds and its impact on angiogenesis and macrophages. Int Immunopharmacol. 2024;126:111283.","journal-title":"Int Immunopharmacol"},{"key":"7331_CR115","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1186\/s12967-024-05463-6","volume":"22","author":"T Wang","year":"2024","unstructured":"Wang T, et al. METTL3-mediated NDUFB5 m6A modification promotes cell migration and mitochondrial respiration to promote the wound healing of diabetic foot ulcer. J Transl Med. 2024;22:643.","journal-title":"J Transl Med"},{"key":"7331_CR116","doi-asserted-by":"crossref","unstructured":"Liu Y et al. Metformin ameliorates testicular damage in male mice with streptozotocin-induced Type 1 diabetes through the PK2\/PKR Pathway. Oxid Med Cell Longev 2019, 5681701 (2019).","DOI":"10.1155\/2019\/5681701"},{"key":"7331_CR117","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4093\/dmj.2021.0306","volume":"47","author":"Y Tian","year":"2023","unstructured":"Tian Y, Xiao YH, Sun C, Liu B, Sun F. N6-Methyladenosine methyltransferase METTL3 alleviates Diabetes-Induced testicular damage through modulating TUG1\/Clusterin axis. Diabetes Metab J. 2023;47:287\u2013300.","journal-title":"Diabetes Metab J"},{"key":"7331_CR118","doi-asserted-by":"publisher","first-page":"40843","DOI":"10.18632\/oncotarget.17257","volume":"8","author":"J Wu","year":"2017","unstructured":"Wu J, et al. High glucose induces formation of Tau hyperphosphorylation via Cav-1-mTOR pathway: A potential molecular mechanism for diabetes-induced cognitive dysfunction. Oncotarget. 2017;8:40843\u201356.","journal-title":"Oncotarget"},{"key":"7331_CR119","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41419-023-05909-7","volume":"14","author":"M Qu","year":"2023","unstructured":"Qu M, et al. High glucose induces Tau hyperphosphorylation in hippocampal neurons via Inhibition of ALKBH5-mediated Dgkh m(6)A demethylation: a potential mechanism for diabetic cognitive dysfunction. Cell Death Dis. 2023;14:385.","journal-title":"Cell Death Dis"},{"key":"7331_CR120","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1080\/1061186X.2022.2071906","volume":"30","author":"X Liao","year":"2022","unstructured":"Liao X, et al. Metformin combats obesity by targeting FTO in an m(6)A-YTHDF2-dependent manner. J Drug Target. 2022;30:983\u201391.","journal-title":"J Drug Target"},{"key":"7331_CR121","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","volume":"377","author":"RR Holman","year":"2017","unstructured":"Holman RR, et al. Effects of Once-Weekly exenatide on cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2017;377:1228\u201339.","journal-title":"N Engl J Med"},{"key":"7331_CR122","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2337\/db06-1601","volume":"56","author":"J Pi","year":"2007","unstructured":"Pi J, et al. Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes. 2007;56:1783\u201391.","journal-title":"Diabetes"},{"key":"7331_CR123","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.bbagen.2017.05.013","volume":"1861","author":"S Lenzen","year":"2017","unstructured":"Lenzen S. Chemistry and biology of reactive species with special reference to the antioxidative defence status in pancreatic \u03b2-cells. Biochim Biophys Acta Gen Subj. 2017;1861:1929\u201342.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"7331_CR124","doi-asserted-by":"publisher","first-page":"174960","DOI":"10.1016\/j.ejphar.2022.174960","volume":"924","author":"S Zhou","year":"2022","unstructured":"Zhou S, et al. Exenatide ameliorates hydrogen peroxide-induced pancreatic \u03b2-cell apoptosis through regulation of METTL3-mediated m(6)A methylation. Eur J Pharmacol. 2022;924:174960.","journal-title":"Eur J Pharmacol"},{"key":"7331_CR125","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2165\/00003495-199957060-00007","volume":"57","author":"JA Balfour","year":"1999","unstructured":"Balfour JA, Plosker GL. Rosiglitazone Drugs. 1999;57:921\u201330. discussion 931\u2009\u2013\u2009922.","journal-title":"Rosiglitazone Drugs"},{"key":"7331_CR126","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/db10-0281","volume":"60","author":"A Bravard","year":"2011","unstructured":"Bravard A, et al. FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction. Diabetes. 2011;60:258\u201368.","journal-title":"Diabetes"},{"key":"7331_CR127","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07848","volume":"458","author":"J Fischer","year":"2009","unstructured":"Fischer J, et al. Inactivation of the Fto gene protects from obesity. Nature. 2009;458:894\u20138.","journal-title":"Nature"},{"key":"7331_CR128","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jep.2011.03.012","volume":"135","author":"J Guo","year":"2011","unstructured":"Guo J, et al. A new TCM formula FTZ lowers serum cholesterol by regulating HMG-CoA reductase and CYP7A1 in hyperlipidemic rats. J Ethnopharmacol. 2011;135:299\u2013307.","journal-title":"J Ethnopharmacol"},{"key":"7331_CR129","doi-asserted-by":"publisher","first-page":"116766","DOI":"10.1016\/j.jep.2023.116766","volume":"317","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, et al. Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m(6)A modification of SIRT3 mRNA. J Ethnopharmacol. 2023;317:116766.","journal-title":"J Ethnopharmacol"},{"key":"7331_CR130","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.tem.2013.12.001","volume":"25","author":"HC Chang","year":"2014","unstructured":"Chang HC, Guarente L. SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab. 2014;25:138\u201345.","journal-title":"Trends Endocrinol Metab"},{"key":"7331_CR131","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/ars.2017.7290","volume":"28","author":"CK Singh","year":"2018","unstructured":"Singh CK, et al. The role of sirtuins in antioxidant and redox signaling. Antioxid Redox Signal. 2018;28:643\u201361.","journal-title":"Antioxid Redox Signal"},{"key":"7331_CR132","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.phrs.2017.05.019","volume":"122","author":"R Zhu","year":"2017","unstructured":"Zhu R, et al. Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety. Pharmacol Res. 2017;122:78\u201389.","journal-title":"Pharmacol Res"},{"key":"7331_CR133","doi-asserted-by":"publisher","first-page":"113367","DOI":"10.1016\/j.biopha.2022.113367","volume":"153","author":"R Xu","year":"2022","unstructured":"Xu R, et al. The methyltransferase METTL3-mediated fatty acid metabolism revealed the mechanism of cinnamaldehyde on alleviating steatosis. Biomed Pharmacother. 2022;153:113367.","journal-title":"Biomed Pharmacother"},{"key":"7331_CR134","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1053\/j.ajkd.2015.04.013","volume":"66","author":"Y Zhong","year":"2015","unstructured":"Zhong Y, Menon MC, Deng Y, Chen Y, He JC. Recent advances in traditional Chinese medicine for kidney disease. Am J Kidney Dis. 2015;66:513\u201322.","journal-title":"Am J Kidney Dis"},{"key":"7331_CR135","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ptr.6818","volume":"35","author":"N Li","year":"2021","unstructured":"Li N, et al. Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases. Phytother Res. 2021;35:198\u2013206.","journal-title":"Phytother Res"},{"key":"7331_CR136","doi-asserted-by":"crossref","unstructured":"Lin J et al. New insights into the mechanisms of pyroptosis and implications for diabetic kidney disease. Int J Mol Sci 21, (2020).","DOI":"10.3390\/ijms21197057"},{"key":"7331_CR137","doi-asserted-by":"publisher","first-page":"117138","DOI":"10.1016\/j.lfs.2019.117138","volume":"240","author":"ZW Yu","year":"2020","unstructured":"Yu ZW, et al. A new research hot spot: the role of NLRP3 inflammasome activation, a key step in pyroptosis, in diabetes and diabetic complications. Life Sci. 2020;240:117138.","journal-title":"Life Sci"},{"key":"7331_CR138","doi-asserted-by":"publisher","first-page":"667644","DOI":"10.3389\/fphar.2021.667644","volume":"12","author":"BH Liu","year":"2021","unstructured":"Liu BH, et al. Total flavones of Abelmoschus manihot ameliorates podocyte pyroptosis and injury in high glucose conditions by targeting METTL3-Dependent m(6)A Modification-Mediated NLRP3-Inflammasome activation and PTEN\/PI3K\/Akt signaling. Front Pharmacol. 2021;12:667644.","journal-title":"Front Pharmacol"},{"key":"7331_CR139","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/jsfa.10152","volume":"100","author":"B Tian","year":"2020","unstructured":"Tian B, Liu J. Resveratrol: a review of plant sources, synthesis, stability, modification and food application. J Sci Food Agric. 2020;100:1392\u2013404.","journal-title":"J Sci Food Agric"},{"key":"7331_CR140","doi-asserted-by":"publisher","first-page":"568006","DOI":"10.3389\/fphar.2020.568006","volume":"11","author":"J Wu","year":"2020","unstructured":"Wu J, et al. Resveratrol attenuates High-Fat diet induced hepatic lipid homeostasis disorder and decreases m(6)A RNA methylation. Front Pharmacol. 2020;11:568006.","journal-title":"Front Pharmacol"},{"key":"7331_CR141","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1080\/10408398.2016.1231168","volume":"58","author":"RY Gan","year":"2018","unstructured":"Gan RY, Li HB, Sui ZQ, Corke H. Absorption, metabolism, anti-cancer effect and molecular targets of Epigallocatechin gallate (EGCG): an updated review. Crit Rev Food Sci Nutr. 2018;58:924\u201341.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"7331_CR142","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/s41366-018-0082-5","volume":"42","author":"R Wu","year":"2018","unstructured":"Wu R, et al. Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m(6)A-YTHDF2-dependent manner. Int J Obes (Lond). 2018;42:1378\u201388.","journal-title":"Int J Obes (Lond)"},{"key":"7331_CR143","doi-asserted-by":"publisher","first-page":"107343","DOI":"10.1016\/j.biotechadv.2019.01.010","volume":"38","author":"H Li","year":"2020","unstructured":"Li H, et al. Curcumin, the golden spice in treating cardiovascular diseases. Biotechnol Adv. 2020;38:107343.","journal-title":"Biotechnol Adv"},{"key":"7331_CR144","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.fct.2011.02.004","volume":"49","author":"MA El-Moselhy","year":"2011","unstructured":"El-Moselhy MA, Taye A, Sharkawi SS, El-Sisi SF, Ahmed AF. The antihyperglycemic effect of Curcumin in high fat diet fed rats. Role of TNF-\u03b1 and free fatty acids. Food Chem Toxicol. 2011;49:1129\u201340.","journal-title":"Food Chem Toxicol"},{"key":"7331_CR145","doi-asserted-by":"publisher","first-page":"e52146","DOI":"10.15252\/embr.202052146","volume":"22","author":"Y Chen","year":"2021","unstructured":"Chen Y, et al. Curcumin prevents obesity by targeting TRAF4-induced ubiquitylation in m(6) A-dependent manner. EMBO Rep. 2021;22:e52146.","journal-title":"EMBO Rep"},{"key":"7331_CR146","doi-asserted-by":"publisher","first-page":"17963","DOI":"10.1021\/ja3064149","volume":"134","author":"B Chen","year":"2012","unstructured":"Chen B, et al. Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. J Am Chem Soc. 2012;134:17963\u201371.","journal-title":"J Am Chem Soc"},{"key":"7331_CR147","doi-asserted-by":"crossref","unstructured":"Mizuno TM. Fat Mass and obesity associated (FTO) gene and hepatic glucose and lipid metabolism. Nutrients 10, (2018).","DOI":"10.20944\/preprints201810.0166.v1"},{"key":"7331_CR148","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4183\/aeb.2021.26","volume":"17","author":"TM Mizuno","year":"2021","unstructured":"Mizuno TM, Lew PS. Regulation of activating transcription factor 4 (ATF4) expression by fat mass and Obesity-Associated (FTO) in mouse hepatocyte cells. Acta Endocrinol (Buchar). 2021;17:26\u201332.","journal-title":"Acta Endocrinol (Buchar)"},{"key":"7331_CR149","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1021\/acs.accounts.3c00451","volume":"56","author":"Y Huang","year":"2023","unstructured":"Huang Y, Xia W, Dong Z, Yang CG. Chemical inhibitors targeting the oncogenic m(6)A modifying proteins. Acc Chem Res. 2023;56:3010\u201322.","journal-title":"Acc Chem Res"},{"key":"7331_CR150","doi-asserted-by":"crossref","unstructured":"Zhang Y et al. Rhein Reduces fat weight in db\/db mouse and prevents diet-induced obesity in C57Bl\/6 mouse through the inhibition of PPAR\u03b3 signaling. PPAR Res 2012, 374936 (2012).","DOI":"10.1155\/2012\/374936"},{"key":"7331_CR151","doi-asserted-by":"publisher","first-page":"1106260","DOI":"10.3389\/fphar.2022.1106260","volume":"13","author":"T Deng","year":"2022","unstructured":"Deng T, et al. Rhein for treating diabetes mellitus: A Pharmacological and mechanistic overview. Front Pharmacol. 2022;13:1106260.","journal-title":"Front Pharmacol"},{"key":"7331_CR152","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/nar\/gku1276","volume":"43","author":"Y Huang","year":"2015","unstructured":"Huang Y, et al. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic Acids Res. 2015;43:373\u201384.","journal-title":"Nucleic Acids Res"},{"key":"7331_CR153","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.cmet.2021.04.001","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. Cell Metab. 2021;33:1221\u2013e12331211.","journal-title":"Cell Metab"},{"key":"7331_CR154","doi-asserted-by":"publisher","first-page":"663295","DOI":"10.3389\/fimmu.2021.663295","volume":"12","author":"J Luo","year":"2021","unstructured":"Luo J, et al. Targeted Inhibition of FTO demethylase protects mice against LPS-Induced septic shock by suppressing NLRP3 inflammasome. Front Immunol. 2021;12:663295.","journal-title":"Front Immunol"},{"key":"7331_CR155","doi-asserted-by":"crossref","unstructured":"Peng S et al. Identification of Entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1. Sci Transl Med 11, (2019).","DOI":"10.1126\/scitranslmed.aau7116"},{"key":"7331_CR156","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1021\/acs.jmedchem.4c03124","volume":"68","author":"D Ma","year":"2025","unstructured":"Ma D, et al. Discovery of the 2,3-Dihydrobenzopyrane-4-one as a potent FTO inhibitor against Obesity-Related metabolic diseases. J Med Chem. 2025;68:7421\u201340.","journal-title":"J Med Chem"},{"key":"7331_CR157","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/mds.30162","volume":"40","author":"RMA de Bie","year":"2025","unstructured":"de Bie RMA, et al. Update on treatments for parkinson\u2019s disease motor Fluctuations - An international Parkinson and movement disorder society Evidence-Based medicine review. Mov Disord. 2025;40:776\u201394.","journal-title":"Mov Disord"},{"issue":"Suppl 2","key":"7331_CR158","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/ene.15993","volume":"30","author":"W Poewe","year":"2023","unstructured":"Poewe W. Catechol-O-methyltransferase Inhibition with entacapone: evidence from controlled clinical trials in parkinson\u2019s disease. Eur J Neurol. 2023;30(Suppl 2):9\u201314.","journal-title":"Eur J Neurol"},{"key":"7331_CR159","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","volume":"142","author":"DY Oh","year":"2010","unstructured":"Oh DY, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010;142:687\u201398.","journal-title":"Cell"},{"key":"7331_CR160","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.tem.2022.12.006","volume":"34","author":"X Zhu","year":"2023","unstructured":"Zhu X, Tang H, Yang M, Yin K. N6-methyladenosine in macrophage function: a novel target for metabolic diseases. Trends Endocrinol Metab. 2023;34:66\u201384.","journal-title":"Trends Endocrinol Metab"},{"key":"7331_CR161","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41556-024-01368-0","volume":"26","author":"DF De Jesus","year":"2024","unstructured":"De Jesus DF, et al. Redox regulation of m(6)A methyltransferase METTL3 in \u03b2-cells controls the innate immune response in type 1 diabetes. Nat Cell Biol. 2024;26:421\u201337.","journal-title":"Nat Cell Biol"},{"key":"7331_CR162","doi-asserted-by":"publisher","first-page":"148894","DOI":"10.1016\/j.gene.2024.148894","volume":"931","author":"S Zhang","year":"2024","unstructured":"Zhang S, et al. METTL3 mediates m6A modification of hsa_circ_0072380 to regulate the progression of gestational diabetes mellitus. Gene. 2024;931:148894.","journal-title":"Gene"},{"key":"7331_CR163","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10020-023-00615-8","volume":"29","author":"J Fang","year":"2023","unstructured":"Fang J, et al. RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4. Mol Med. 2023;29:23.","journal-title":"Mol Med"},{"key":"7331_CR164","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ygeno.2021.02.016","volume":"113","author":"J Wang","year":"2021","unstructured":"Wang J, Wang K, Liu W, Cai Y, Jin H. m6A mRNA methylation regulates the development of gestational diabetes mellitus in Han Chinese women. Genomics. 2021;113:1048\u201356.","journal-title":"Genomics"},{"key":"7331_CR165","doi-asserted-by":"publisher","first-page":"115820","DOI":"10.1016\/j.ejmech.2023.115820","volume":"261","author":"P Bakun","year":"2023","unstructured":"Bakun P, et al. Tea-break with Epigallocatechin gallate derivatives - Powerful polyphenols of great potential for medicine. Eur J Med Chem. 2023;261:115820.","journal-title":"Eur J Med Chem"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07331-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07331-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07331-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:03:37Z","timestamp":1763467417000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07331-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":165,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7331"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07331-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1308"}}